KRAS and cancer: Note that functionally, the identified driver and follower sites do not show an enrichment trend in oncogenic mutations observed in human cancers (from 2266 missense K-Ras mutations observed in all cancers within cBioPortal www.cbioportal.org on July 28, 2016).